loading

Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
3.96%
224.93
234.21 568.44 66.85 65.82
Nonoperating Income/Loss
137.92%
5.753
2.418 2.729 3.938 13.10
Income/Loss From Continuing Operations Before Tax
5.44%
-219.17
-231.79 -565.71 -62.91 -61.20
Income/Loss From Continuing Operations After Tax
5.44%
-219.17
-231.79 -565.71 -62.91 -61.20
Net Income/Loss
5.44%
-219.17
-231.79 -565.71 -62.91 -61.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.15%
6.3137
743.42 742.62 738.08 6.3735
Diluted Average Shares
99.15%
6.3137
743.42 742.62 738.08 6.3735
Basic Earnings Per Share
9.68%
-0.28
-0.31 -0.76 -0.09 -0.09
Diluted Earnings Per Share
9.68%
-0.28
-0.31 -0.76 -0.09 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$96.90
price up icon 0.05%
$57.16
price down icon 0.82%
$35.72
price up icon 0.62%
$219.72
price down icon 4.96%
ONC ONC
$358.07
price down icon 0.20%
$206.64
price up icon 0.36%
Capitalizzazione:     |  Volume (24 ore):